Regulation and analysis of systemic and local effect of TNF

TNF全身和局部效应的调控与分析

基本信息

  • 批准号:
    04454189
  • 负责人:
  • 金额:
    $ 3.97万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
  • 财政年份:
    1992
  • 资助国家:
    日本
  • 起止时间:
    1992 至 1993
  • 项目状态:
    已结题

项目摘要

I.We analyzed the structure of the 5' end of the mouse CD14 (mCD14) gene. Sequentially 5'-deleted, chimeric and point mutated clones were tested for their ability to stimulate chroramphnicol acetyltransferase (CAT). An 8-base pair sequence, TGATTCAC, at position -255 enhanced the expression of the CAT gene in macrophage cell lines. The 5' upstream of the human CD14 gene were sequenced and compared with that of mouse. II.Recombinant mCD14 protein was deleted at carboxyterminus was produced in E.coli. We made monoclonal antibodies (mAb) against the protein. Immunohistochemical staining using mAb showed that CD14-positive Kupffer cells (KC) were small in number in the liver in nonstimulated mice. The number of stained KC gradually increased with time after intraperitoneal injection of LPS, peaked 6 h after injection, and returned to normal by 20 h after injection. Slight increase in mCD14 expression was observed in peritoneal macrophages 2 h after LPS administration in vivo using flow cytometric analysis. Unique features of mCD14 expression in KC were also confirmed by the expression of mCD14 mRNA which peaked at 3 h after LPS administration. Mice bearing a mCD14 transgene controlled by an metallotionein promoter (MTTG) were produced. Northen blot analysis of MTTG showed that the mice strongly expressed mCD14 mRNA in the liver, small intestine and testis. III.Mice bearing a TNFalpha transgene controlled by an insulin promoter developed an increasingly severe insulitis. Diabetes never divelopped, even though a number of potentially inducing conditions were used, including the prolonged perfusion of TFNgamma and the permanent expression of a non-tolerogenic viral protein on beta cells.

项目成果

期刊论文数量(56)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
山本俊輔: "好中球、" 中山書店(印刷中), (1994)
山本俊辅:《中性粒细胞》,中山书店(正在出版),(1994)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Yasunori Higuchi: "Expression of a tumor necrosis factor-α transgene in murine pancreatic β cells results in severe and parmanent insulitis without evolution towards diabetes" J.Exp.Med.176. 1719-1731 (1992)
Yasunori Higuchi:“小鼠胰腺 β 细胞中肿瘤坏死因子-α 转基因的表达会导致严重且永久性的胰岛炎,但不会发展为糖尿病”J.Exp.Med.176-1719-1731 (1992)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Matsuura, K.et al.: "Identification of a tissue-specific regulatory element in the murine CD14 gene" Journal Experimental Medicine. (in press).
Matsuura, K.et al.:“小鼠 CD14 基因中组织特异性调节元件的鉴定”实验医学杂志。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Ohashi, P.S.et al.: "Induction of diabetes is influenced by the infectious virus and local expression of MHC class I and tumor necrosis factor-alpha" Journal of Immunology. 150(11). 5185-5194 (1992)
Ohashi, P.S.等人:“糖尿病的诱发受到传染性病毒以及 MHC I 类和肿瘤坏死因子-α 局部表达的影响”《免疫学杂志》。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Higuchi, Y.et al.: "Expression of a tumor necrosis factor-alpha transgene in murine pancreatic beta cells results in severe and permanent insulitis without evolution towards diabetes" Journal Experimental Medicine. 176(6). 1719-1731 (1992)
Higuchi, Y.等人:“在小鼠胰腺β细胞中表达肿瘤坏死因子-α转基因会导致严重且永久性的胰岛炎,而不会演变成糖尿病”《实验医学杂志》。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

HIGUCHI Yasunori其他文献

HIGUCHI Yasunori的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('HIGUCHI Yasunori', 18)}}的其他基金

From analysis of osteopontin function to development of preventive and medical treatment for osteoporosis.
从骨桥蛋白功能分析到骨质疏松症预防和治疗的发展。
  • 批准号:
    21591951
  • 财政年份:
    2009
  • 资助金额:
    $ 3.97万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Mechanisms ofpromoting the bone invasion of cancer cells by osteopontin
骨桥蛋白促进癌细胞骨侵袭的机制
  • 批准号:
    18592190
  • 财政年份:
    2006
  • 资助金额:
    $ 3.97万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
In vivo analysis of osteopontin function
骨桥蛋白功能的体内分析
  • 批准号:
    08457074
  • 财政年份:
    1996
  • 资助金额:
    $ 3.97万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Fundamental studies of regularion for endotoxin shock by CD14
CD14对内毒素休克调节的基础研究
  • 批准号:
    05557057
  • 财政年份:
    1993
  • 资助金额:
    $ 3.97万
  • 项目类别:
    Grant-in-Aid for Developmental Scientific Research (B)
Molecular pathology of osteopontin transgenic mice
骨桥蛋白转基因小鼠的分子病理学
  • 批准号:
    06454194
  • 财政年份:
    1993
  • 资助金额:
    $ 3.97万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)

相似国自然基金

m6A识别蛋白YTHDC2通过星形胶质细胞LCN2调控IKK/NF-κB/TNFα轴在颞叶癫痫的作用及机制研究
  • 批准号:
    82371463
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
TNFR2/Hippo/YAP轴介导TNFα上调肝窦内皮细胞BMP6表达在铁过载相关疾病中的作用及机制研究
  • 批准号:
    82370898
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
Ufmylation修饰调控NF-κB介导TNF/IL6/STAT3信号通路在DBP致小鼠睾丸铁死亡的机制研究
  • 批准号:
    82360634
  • 批准年份:
    2023
  • 资助金额:
    31 万元
  • 项目类别:
    地区科学基金项目
CXCL2/TNF-α介导平滑肌细胞和在位内膜间质细胞的交互作用促进子宫腺肌病发病的机制研究
  • 批准号:
    82301858
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
调节性B细胞通过TNF-α/TNFR2信号通路诱导调节性T细胞及调控移植免疫的机理研究
  • 批准号:
    82302007
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Znf740 in the regulation of CD8+T cell exhaustion
Znf740 调节 CD8 T 细胞耗竭
  • 批准号:
    10715852
  • 财政年份:
    2023
  • 资助金额:
    $ 3.97万
  • 项目类别:
Therapeutic benefit of targeting neuroinflammation in spinal cord injury with a novel small molecule inhibitor of the RNA regulator HuR
使用 RNA 调节因子 HuR 的新型小分子抑制剂针对脊髓损伤中的神经炎症的治疗益处
  • 批准号:
    10472150
  • 财政年份:
    2022
  • 资助金额:
    $ 3.97万
  • 项目类别:
Intranasal gene delivery for Alzheimer’s disease
鼻内基因递送治疗阿尔茨海默病
  • 批准号:
    10308277
  • 财政年份:
    2021
  • 资助金额:
    $ 3.97万
  • 项目类别:
DEVELOPMENT OF NOVEL AMINOGLYCOSIDE POLYMERS AND NANOPARTICLES FOR NUCLEIC ACID DELIVERY IN CHRONIC WOUNDS
开发用于慢性伤口核酸输送的新型氨基糖苷聚合物和纳米颗粒
  • 批准号:
    10009545
  • 财政年份:
    2020
  • 资助金额:
    $ 3.97万
  • 项目类别:
Muscle Stem Cells Reprogrammed Through Genome Engineering for Autonomously Regulated Anti-Fibrotic Therapy
通过基因组工程重新编程肌肉干细胞以进行自主调节的抗纤维化治疗
  • 批准号:
    9917939
  • 财政年份:
    2019
  • 资助金额:
    $ 3.97万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了